Note: Some of these drugs are not in trials yet or are not in trials that we are monitoring for GIST.
Note: Click on a column title to sort the list
Targets |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tasigna + Gleevec |
Novartis |
||||||||||||
Taxol |
Pfizer |
|
|||||||||||
Temodar |
Schering-Plough |
|
|||||||||||
Torisel |
Wheth Pharmaceuticals |
|
|||||||||||
Velcade |
Millennium |
|
|||||||||||
Velcade + Sutent |
Millennium |
|
|||||||||||
Venclexta |
Abbvie / Genetech |
|
|||||||||||
Votrient |
GlaxoSmithKline |
|
|||||||||||
Votrient + Hycamtin |
GlaxoSmithKline |
|
|||||||||||
Votrient + Zolinza |
GlaxoSmithKline & Merck |
|
|||||||||||
Yervoy |
Bristol-Myers Squibb |
|
|||||||||||
Yondelis |
Johnson & Johnson |
||||||||||||
Zelboraf |
Plexxicon |
|
|||||||||||
Zolinza |
Merck |
|
|||||||||||
Zolinza + Nexavar |
Merck + Bayer |
|
|||||||||||